Search

everythinglearnresearchcommunity

for

Search:↓

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Alternative treatments show promise for hair growth beyond traditional methods.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Young women with PCOS and no other heart risk factors have normal heart function.

Finasteride helps female-pattern hair loss.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.